Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Axogen Inc (NQ: AXGN )

9.730 -0.480 (-4.70%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 30, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 273,640
Open 9.950
Bid (Size) 9.470 (5)
Ask (Size) 9.740 (3)
Prev. Close 10.21
Today's Range 9.300 - 10.01
52wk Range 6.870 - 13.66
Shares Outstanding 41,397,053
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2022
From Axogen, Inc.
Via Globe NewsWire
Axogen Announces Independent Publication of Comparative Nerve Gap Repair Meta-Analysis of 35 peer-reviewed studies of Allograft, Autograft, and Conduits
Study concluded allograft and autograft repairs delivered significantly better rates of meaningful sensory recovery in short gaps as compared to conduit repairs in a systematic meta-analysis including... 
From Axogen, Inc.
Via Globe NewsWire

Performance

YTD
-1.52%
-1.52%
1 Month
-1.52%
-1.52%
3 Month
-14.80%
-14.80%
6 Month
-0.21%
-0.21%
1 Year
+11.71%
+11.71%

More News

Read More
Axogen to Participate at J.P. Morgan 41st Annual Healthcare Conference
From Axogen, Inc.
Via Globe NewsWire
Read JMP Securities' Take On Axogen's Interim Update
Via Benzinga
Axogen Aces Phase 3 Study For Avance Nerve Graft
Via Benzinga
Axogen: Q4 Earnings Insights
Via Benzinga
Axogen Patient to Ride the 2023 Donate Life Rose Parade® Float Supporting awareness of organ and tissue donation
From Axogen, Inc.
Via Globe NewsWire
Axogen, Inc Reports 2022 Third Quarter Financial Results
From Axogen, Inc.
Via Globe NewsWire
Axogen to Participate at Upcoming Investor Conferences
From Axogen, Inc.
Via Globe NewsWire
Earnings Scheduled For February 22, 2022
Via Benzinga
Axogen, Inc. announces the appointment of Adrian Tyndall, M.D. MPH, FACEP to its Board of Directors and the retirement of founding Director Mark Gold, M.D.
From Axogen, Inc.
Via Globe NewsWire
Axogen, Inc. to report third quarter 2022 financial results and host conference call on November 8, 2022
From Axogen, Inc.
Via Globe NewsWire
Axogen: Q2 Earnings Insights
Via Benzinga
Why Immunocore Shares Dipped 22%; Here Are 73 Biggest Movers From Friday
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 9, 2022
Via Benzinga
83 Biggest Movers From Yesterday
Via Benzinga
Mid-Afternoon Market Update: Nasdaq Drops 650 Points; Silicon Motion Shares Spike Higher
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Mid-Day Market Update: U.S. Stocks Extend Losses; Dow Dips Over 1,100 Points
Via Benzinga
The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study
Via Benzinga
57 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
The Daily Biotech Pulse: Kezar Life's Lead Asset Fails, Brickell Biotech Offloads Late-Stage Asset, Connect Biopharma Ulcerative Colitis Trial Disappoints
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
63 Biggest Movers From Friday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.